Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Vaccine|June 28, 2011
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccineFrancisco Gimenez-Sanchez, Dorothee M Kieninger, Kathrin Kueper, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2018
Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditisKathleen Pappritz, Konstantinos Savvatis, Kapka Miteva, et al.
Vaccine|September 6, 2013
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in SpainJavier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, et al.
Vaccine|August 23, 2013
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleGail L Rodgers, Susanna Esposito, Nicola Principi, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?Susanna Esposito, Robert Cohen, Javier Diez Domingo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 26, 2016
Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complicationsJavier Diez-Domingo, Maurizio de Martino, Jose Garcia-Sicilia Lopez, et al.
The Pediatric Infectious Disease Journal|January 13, 2016
Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of AgeMatthew D Snape, Merryn Voysey, Adam Finn, et al.
Vaccine|April 3, 2019
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trialsMarta López-Fauqued, Laura Campora, Frédérique Delannois, et al.
Diabetes Care|June 10, 2016
Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and RetinopathyJordi Sanahuja, Núria Alonso, Javier Diez, et al.
Circulation. Cardiovascular Imaging|June 9, 2022
Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-ReperfusionRafael Ramirez-Carracedo, Marcelo Sanmartin, Amadeo Ten, et al.
Pageof 18